EGR1驱动的METTL3激活阻碍了中VIM介导的神经损伤
Zhaofei Dong1, Fuli Min2, Sai Zhang2
1Department of Neurology, The Eighth Affiliated Hospital, Sun Yat-Sen University, Shenzhen, 518033, People's Republic of China.
Neurochemical research
|June 2, 2023
概括
早期生长反应1 (EGR1) 通过减少神经元损伤来预防. EGR1激活METTL3,然后抑制维门 (VIM) 表达,为治疗提供新的途径.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 的研究研究.
背景情况:
- 了解发生过程对于开发有效的治疗方法至关重要.
- 鉴定中神经元损伤的基础分子机制是一个关键的研究领域.
研究的目的:
- 调查早期生长反应1 (EGR1) 在中的抗原和神经保护作用.
- 阐明EGR1在模型中影响神经元损伤和亡的分子机制.
主要方法:
- 生物信息学分析以确定与有关的关键基因.
- 在体内 (在小鼠中因酸诱导的) 和体外 (培养的神经元) 模型.
- 功能丧失和增益研究,评估神经元损伤,细胞亡和炎症反应.
- 机械实验分析EGR1,METTL3和Vimentin (VIM) 之间的相互作用.
主要成果:
- 在模型中,维丁 (VIM) 表达被显著诱导,其敲击减少了神经元损伤和亡.
- 发现EGR1可以转录激活METTL3.
- 反过来,METTL3通过m6A修饰来下调VIM表达,从而减少神经元损伤和亡.
结论:
- 通过促进METTL3介导的VIM抑制,EGR1在中发挥神经保护作用.
- 这种EGR1-METTL3-VIM通路代表了预防进展和减少神经元损伤的新疗法标.
关键词:
在 EGR1 里面,你会看到 EGR1 的位置.是一种病.河马神经元的神经元在METTL3中,METTL3是METTL3的第一个类型.VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM VIM Vim Vim Vim Vim Vim Vim Vim Vim Vim Vim Vim Vim Vim Vim Vim Vim Vim Vim Vim Vim Vim Vim Vim Vim Vim Vim Vim Vm6A 修改的修改更多相关视频
09:07Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
Published on: August 15, 2017
12.1K
07:07Inducing Post-Traumatic Epilepsy in a Mouse Model of Repetitive Diffuse Traumatic Brain Injury
Published on: February 10, 2020
10.6K
相关概念视频
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
354
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
354
01:24Epilepsy and Seizures: Overview
230
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
230
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.3K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.3K